These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9494919)

  • 21. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
    Williams MA; Hickok DE; Zingheim RW; Luthy DA; Kimelman J; Nyberg DA; Mahony BS
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels.
    Morssink LP; Sikkema-Raddatz B; Beekhuis JR; De Wolf BT; Mantingh A
    Prenat Diagn; 1996 Sep; 16(9):845-51. PubMed ID: 8905899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
    Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
    Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance affect pregnancy outcome?
    Huerta-Enochian G; Katz V; Erfurth S
    Am J Obstet Gynecol; 2001 Jun; 184(7):1549-53; discussion 1553-5. PubMed ID: 11408879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels.
    Puntachai P; Wanapirak C; Sirichotiyakul S; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Tongsong T
    Arch Gynecol Obstet; 2015 Jul; 292(1):81-5. PubMed ID: 25547063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between second-trimester maternal serum alpha-fetoprotein in 14-22 weeks and adverse pregnancy outcome.
    Dehghani-Firouzabadi R; Tayebi N; Ghasemi N; Tahmasbi Z
    Acta Med Iran; 2010; 48(4):234-8. PubMed ID: 21279936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between second trimester maternal serum alpha-fetoprotein and umbilical artery Doppler velocimetry and their association with preterm delivery.
    Weiner CP; Grant SS; Williamson RA
    Am J Perinatol; 1991 Jul; 8(4):263-8. PubMed ID: 1720619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
    Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
    J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal serum levels of alpha-fetoprotein and fetal fibronectin as markers of labor in the third trimester.
    Khandelwal M; Lynch L; Lockwood CJ; Ainbender E
    Am J Perinatol; 1995 May; 12(3):161-3. PubMed ID: 7541997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperechogenic fetal bowel and elevated serum alpha-fetoprotein: a poor fetal prognosis.
    Achiron R; Seidman DS; Horowitz A; Mashiach S; Goldman B; Lipitz S
    Obstet Gynecol; 1996 Sep; 88(3):368-71. PubMed ID: 8752241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening.
    van Rijn M; van der Schouw YT; Hagenaars AM; Visser GH; Christiaens GC
    Obstet Gynecol; 1999 Dec; 94(6):929-34. PubMed ID: 10576178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
    Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
    Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
    Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine artery Doppler velocimetry in the prediction of adverse obstetric outcomes in unexplained MSAFP elevations.
    Chung JE; Cho JS; Han SS; Park YW; Kim JW
    Yonsei Med J; 2000 Feb; 41(1):17-21. PubMed ID: 10731914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1).
    Krause TG; Christens P; Wohlfahrt J; Lei U; Westergaard T; Nørgaard-Pedersen B; Melbye M
    Obstet Gynecol; 2001 Feb; 97(2):277-82. PubMed ID: 11165595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrence Rate for Isolated Elevated Maternal Serum Alpha-Fetoprotein Levels and Pregnancy Outcomes.
    Ayyash M; Keerthy M; Roberson J; Shaman M
    Genet Test Mol Biomarkers; 2022 Sep; 26(9):443-448. PubMed ID: 36166740
    [No Abstract]   [Full Text] [Related]  

  • 38. Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
    Kuo PL; Lin CC; Lin YH; Guo HR
    J Formos Med Assoc; 2003 May; 102(5):319-25. PubMed ID: 12874670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results].
    Cox M U; Kingdom J; Whittle M; McNay M; Fleming J; Bowman A; Crossley J; Aitken D
    Rev Chil Obstet Ginecol; 1995; 60(3):174-80. PubMed ID: 8728745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
    Konchak PS; Bernstein IM; Capeless EL
    Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.